Literature DB >> 17879412

Heme oxygenase-1 induction by hemin protects liver cells from ischemia/reperfusion injury in cirrhotic rats.

Hui Xue1, Hua Guo, Ying-Chao Li, Zhi-Ming Hao.   

Abstract

AIM: To investigate the potential protective effect of HO-1 on cirrhotic liver cells in rats.
METHODS: Male Wistar rats included in the current study were randomly divided into 5 groups as follows: normal (N) group; liver cirrhotic (LC) group; sham (S) group; I/R group and I/R + hemin group. The model for inducing liver cirrhosis in rats was established according to a previously published protocol. Following this the segmental hepatic ischemia reperfusion operation was carried out. The rats were treated with 30 micromol/kg hemin (HO-1 inducer, ferric portoporphyrin IX chloride) i.p. or 0.9% NaCl (control) 24 h and 12 h before hepatic ischemia for 30 min or sham laparotomy. Blood was collected for serum enzymatic measurement 6 and 12 h after reperfusion or sham laparotomy. HO-1, NF-kappaB and caspase-3 expressions were assessed by immunohistochemical analysis.
RESULTS: The expressions of proteins are inversely correlated to the gray values. HO-1 expression in the I/R + hemin group was increased significantly than I/R group at 6 h and 12 h after hepatic I/R (6 h: 112.0 +/- 8.3 vs 125.1 +/- 5.7, P < 0.01; 12 h: 120.8 +/- 11.0 vs 132.4 +/- 6.2, P < 0.01). Hemin improved serum manganese superoxide dismutase (MnSOD) (6 h: 131.3 +/- 17.6 vs 107.0 +/- 13.9, P < 0.01; 12 h: 141.4 +/- 12.5 vs 118.3 +/- 10.2, P < 0.01), lessened liver cell injury, decreased caspase-3(6 h: 166.7 +/- 8.1 vs 145.5 +/- 14.6, P < 0.01; 12 h: 172.8 +/- 3.8 vs 148.0 +/- 6.5, P < 0.01) and NF-kappaB expression (6 h: 150.2 +/- 8.6 vs 139.7 +/- 6.0, P < 0.01; 12 h: 151.1 +/- 5.9 vs 148.1 +/- 5.3, P > 0.05) and serum alanine aminotransferase (ALT) (6 h: 413.3 +/- 104.1 vs 626.8 +/- 208.2, P < 0.01; 12 h: 322.2 +/- 98.8 vs 425.8 +/- 115.4, P < 0.05), aspartate aminotransferase (AST) (6 h: 665.2 +/- 70.1 vs 864.3 +/- 70.4, P < 0.01; 12 h: 531.1 +/- 98.6 vs 664.4 +/- 115.6, P < 0.01), malondialdehyde (MDA) levels (6 h: 11.1 +/- 2.17 vs 13.5 +/- 2.01, P < 0.01; 12 h: 9.36 +/- 1.10 vs 10.8 +/- 1.62, P < 0.05) in the I/R + hemin group when compared with the I/R group.
CONCLUSION: These results suggest that HO-1 plays an important role in protecting liver cells from hepatic I/R injury in cirrhotic rats by decreasing oxidative stress, apoptosis and inflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17879412      PMCID: PMC4171332          DOI: 10.3748/wjg.v13.i40.5384

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  32 in total

1.  Effects of ischemia and reperfusion on oxidative stress in hepatic cirrhosis induced by carbon tetrachloride in rats.

Authors:  E L Rhoden; L Pereira-Lima; A N Kalil; M L Lucas; M Mauri; E Menti; C R Rhoden; J Pereira-Lima; C G Zettler; A Belló-Klein
Journal:  Kobe J Med Sci       Date:  2000-08

Review 2.  Therapeutic approaches for ischemia/reperfusion injury in the liver.

Authors:  C Fan; R M Zwacka; J F Engelhardt
Journal:  J Mol Med (Berl)       Date:  1999-08       Impact factor: 4.599

3.  Vascular occlusion in hepatic resections in cirrhotic rat livers: an experimental study in rats.

Authors:  J Figueras; L Farran; C Benasco; Y Ribas; E Ramos; F G Borobia; R Fradera; J Castellví; C Lama; E Jaurrieta
Journal:  Liver Transpl Surg       Date:  1997-11

Review 4.  Hepatic ischemia-reperfusion injury.

Authors:  F Serracino-Inglott; N A Habib; R T Mathie
Journal:  Am J Surg       Date:  2001-02       Impact factor: 2.565

Review 5.  Heme oxygenase-1 (HO-1), a protective gene that prevents chronic graft dysfunction.

Authors:  Niels Olsen Saraiva Camara; Miguel Parreira Soares
Journal:  Free Radic Biol Med       Date:  2005-02-15       Impact factor: 7.376

Review 6.  Antioxidants in myocardial ischemia-reperfusion injury: therapeutic potential and basic mechanisms.

Authors:  Nándor Marczin; Nihal El-Habashi; Ginette S Hoare; Ruth E Bundy; Magdi Yacoub
Journal:  Arch Biochem Biophys       Date:  2003-12-15       Impact factor: 4.013

Review 7.  Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection.

Authors:  Narci C Teoh; Geoffrey C Farrell
Journal:  J Gastroenterol Hepatol       Date:  2003-08       Impact factor: 4.029

Review 8.  Current progress in the understanding of and therapeutic strategies for ischemia and reperfusion injury of the liver.

Authors:  Shigeki Arii; Kennichi Teramoto; Toru Kawamura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2003

Review 9.  Role of apoptosis in reperfusion injury.

Authors:  Frank Eefting; Benno Rensing; Jochem Wigman; Willem Jan Pannekoek; Wai Ming Liu; Maarten Jan Cramer; Daniel J Lips; Pieter A Doevendans
Journal:  Cardiovasc Res       Date:  2004-02-15       Impact factor: 10.787

Review 10.  Oxidative stress-elicited myocardial apoptosis during reperfusion.

Authors:  Zhi-Qing Zhao
Journal:  Curr Opin Pharmacol       Date:  2004-04       Impact factor: 5.547

View more
  9 in total

1.  Systemic hemin therapy attenuates blood-brain barrier disruption after intracerebral hemorrhage.

Authors:  Xiangping Lu; Jing Chen-Roetling; Raymond F Regan
Journal:  Neurobiol Dis       Date:  2014-06-18       Impact factor: 5.996

Review 2.  Heme oxygenase-1 system and gastrointestinal tumors.

Authors:  Xiao Zhu; Wen-Guo Fan; Dong-Pei Li; Marie C M Lin; Hsiangfu Kung
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

3.  Protective effects of diallyl sulfide, a garlic constituent, on the warm hepatic ischemia-reperfusion injury in a rat model.

Authors:  Imam H Shaik; Jancy M George; Thomas J Thekkumkara; Reza Mehvar
Journal:  Pharm Res       Date:  2008-07-15       Impact factor: 4.200

4.  Induction of heme oxygenase-1 protects against nutritional fibrosing steatohepatitis in mice.

Authors:  Rong Qi Wang; Yue Min Nan; Wen Juan Wu; Ling Bo Kong; Fang Han; Su Xian Zhao; Li Kong; Jun Yu
Journal:  Lipids Health Dis       Date:  2011-02-12       Impact factor: 3.876

Review 5.  Heme on innate immunity and inflammation.

Authors:  Fabianno F Dutra; Marcelo T Bozza
Journal:  Front Pharmacol       Date:  2014-05-27       Impact factor: 5.810

6.  Investigation of the anti‑asthmatic activity of Oridonin on a mouse model of asthma.

Authors:  Jing Wang; Fengsen Li; Jianbing Ding; Ge Tian; Min Jiang; Zhen Gao; Ehbal Tuyghun
Journal:  Mol Med Rep       Date:  2016-07-08       Impact factor: 2.952

7.  The antifibrotic and fibrolytic properties of date fruit extract via modulation of genotoxicity, tissue-inhibitor of metalloproteinases and nuclear factor- kappa B pathway in a rat model of hepatotoxicity.

Authors:  Hala Attia; Nouf Al-Rasheed; Raeesa Mohamad; Nawal Al-Rasheed; Maha Al-Amin
Journal:  BMC Complement Altern Med       Date:  2016-10-24       Impact factor: 3.659

8.  Shorter Survival after Liver Pedicle Clamping in Patients Undergoing Liver Resection for Hepatocellular Carcinoma Revealed by a Systematic Review and Meta-Analysis.

Authors:  Charles-Henri Wassmer; Beat Moeckli; Thierry Berney; Christian Toso; Lorenzo A Orci
Journal:  Cancers (Basel)       Date:  2021-02-05       Impact factor: 6.639

Review 9.  The Role of Heme Oxygenase-1 in Remote Ischemic and Anesthetic Organ Conditioning.

Authors:  Inge Bauer; Annika Raupach
Journal:  Antioxidants (Basel)       Date:  2019-09-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.